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µg/min—without substantial improvement. Because of
refractory hypotension, 1 unit of vasopressin (20 U/mL;
Fujisawa Canada Inc, Markham, Ontario, Canada) was given.
Mean arterial pressure normalized at about 80 mm Hg, allow-
ing us to taper the phenylephrine and norepinephrine infu-
sions. A second dose of vasopressin was given during CPB for
recurring hypotension. Subsequently, the procedure was
uneventful (Fig 1). The hemoglobin value rose from 34 mg/dL
at the onset of CPB to 54 mg/dL with administration of 2 units
of blood (after vasopressin boluses). Blood gas levels during
CBP are given in Table I. The patient was transferred to the
intensive care unit receiving norepinephrine 4 µg/min and
nitroglycerin 17 µg/min. Vasopressors were stopped and the
patient was extubated on postoperative day 1. She was dis-
charged from the hospital on postoperative day 6, without any
apparent sequel.
Discussion. Vasopressin is a potent endogenous vasocon-
stricting agent, acting through the increase of arteriolar sys-
temic resistances. Many recent studies have shown vaso-
pressin to be effective in the treatment of refractory
hypotension.
Interest has been focused on treatment of hypotension
resulting from distributive shock, as in sepsis or post-CPB
states. These states are characterized by low peripheral vas-
cular resistances, catecholamine-resistant hypotension,
altered peripheral perfusion, and high cardiac output.
Landry and associates1 showed that the blood levels of
vasopressin in septic shock were abnormally low. This find-
ing supports the hypothesis that those patients had depleted
vasopressin stocks and/or dysfunctional baroreflexes that
would cause insufficient vasopressin secretion. They also
reported instances of effective treatment of hypotension
with vasopressin in septic shock.2 After the administration
of vasopressin, the catecholamine needs were reduced and
diuresis improved.
Similar to septic shock, CPB causes an inflammatory
response leading to a vasoplegic state, in which Argenziano
and colleagues3 showed that blood levels of vasopressin were
lower than those in patients with cardiogenic shock. Their ret-
rospective analysis of 40 cases of vasodilatory shock after car-
diac surgery treated with vasopressin showed no rebound
hypertension or mesenteric or peripheral ischemia, along with
an improvement of mean arterial pressure and a diminution of
catecholamine needs. An ejection fraction below 35% and
long-term treatment with angiotensin-converting enzyme
inhibitor predicted vasodilatory shock after CPB.
A 72-year-old, 42-kg woman with aortic stenosis was
referred for coronary arteriography and hemodynamic evalu-
ation. Her history included aorta-bifemoral bypass, hypothy-
roidism, and non–Q wave myocardial infarction (Killip III)
after a carotid endarterectomy. She was on a regimen of
ramipril (discontinued on admission), metoprolol, aspirin,
oral nitrates, furosemide, levothyroxine sodium (Synthroid),
and pravastatin.
Coronary arteriography showed severe tritruncular disease;
hemodynamic evaluation and transthoracic echocardiogra-
phy showed severe aortic disease and grade 2/4 mitral regur-
gitation. Severe diastolic dysfunction and reduced ejection
fraction (35%) with diffuse hypokinesis were present. The
electrocardiogram showed signs of left ventricular hypertro-
phy. A revascularization operation and aortic valve replace-
ment were scheduled. Preoperative work-up revealed cold
agglutinins at 24°C.
On arrival in the operating room, blood pressure was 134/42
mm Hg and the heart rate was 58 beats/min. General anesthe-
sia was induced with sufentanil 60 µg, midazolam 5 mg, and
pancuronium 5 mg. Hemodynamics remained stable until
institution of cardiopulmonary bypass (CPB).
At the beginning of CPB, electrical activity persisted
despite the infusion of large amounts of warm cardioplegic
solution (total 2100 mL); use of hypothermia was limited by
the cold agglutinins. During CPB, the patient became
hypotensive (mean arterial pressure ~40 mm Hg), and with
each bolus of cardioplegic solution, hypotension worsened. In
addition to multiple 100 µg- and 200-µg boluses, a phenyl-
ephrine infusion was started, soon followed by norepineph-
rine. Doses were increased—phenylephrine up to 1 µg · kg–1
· min–1 plus several 200-µg boluses and norepinephrine 12
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We report here the case of a patient with refractory
hypotension at the beginning of CPB. Hemodilution at the
onset of CPB, high circulating potassium concentrations from
the cardioplegic solution, and long-term use of ramipril and
diuretics are the causes. Use of a 1-unit bolus of vasopressin
in this patient with an important history of vascular disease
permitted a rapid correction of the mean arterial perfusion,
while allowing us to taper doses of other pressors without any
noticeable side effect. Efficiency and safety of this promising
new pressor agent during CPB will need confirmation
through a randomized trial.
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Table I.  Blood gas values during CPB
Blood gas values
pH 7.41 7.43 7.33 7.39
Arterial PCO2 (mm Hg) 30 29 37 33
Arterial PO2 (mm Hg) 318 310 323 285
Base excess (mmol/L) –4.6 –4.2 –4.8 –3.4
Lactate (mg/dL) 5.8 6.0 7.2 6.6
Fig 1. Evolution of mean arterial pressure (MAP) and medication given after onset of cardiopulmonary bypass
(CPB). NE, Norepinephrine. 
